Biotechnology and Pharma:  Evolution and Adaptation

Biotechnology and Pharma: Evolution and Adaptation

Tuesday, October 7, 2008

The New York Academy of Sciences

Presented By

Presented by Science Alliance , Columbia University Biotechnology Association and New York University Biotechnology Association

 

 

Moderator: Andrew Marshall, Editor, Nature Biotechnology; Speakers: Ralph Marcello, Senior Manager, Deloitte Consulting LLP; Alan E. Smith, EVP and CSO, Genzyme; Robert A. Copeland, EVP and CSO, EpiZyme, Inc.; Cole Werble, Editor-in-Chief, The RPM Report (Windhover Information, Inc.); Peter Vaccari, Orphan Products Program, FDA; Barbara Mittleman, Office of Science Policy Analysis, NIH

Pharma and biotech provides us medicines and treatments that improve our lives, but these industries face significant challenges of decreased innovation and dwindling drug pipelines. Join us for an expert panel discussion that will address the impact of science, regulation, business and society on the current state of drug development and its designs for the future.